460 related articles for article (PubMed ID: 30390664)
1. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
[TBL] [Abstract][Full Text] [Related]
2. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
3. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
[TBL] [Abstract][Full Text] [Related]
4. Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.
Yang Y; Yin G; Jiang Y; Song L; Zhao S; Lu M
J Cardiovasc Magn Reson; 2020 Jan; 22(1):1. PubMed ID: 31898543
[TBL] [Abstract][Full Text] [Related]
5. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of epicardial adipose tissue volume assessed by cardiac magnetic resonance for atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
Zhou Y; Yu M; Cui J; Hu F; Yang Z; Yuan J; Qiao S
Int J Cardiovasc Imaging; 2021 Apr; 37(4):1383-1393. PubMed ID: 33392874
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.
Nedios S; Dinov B; Seewöster T; Lindemann F; Richter S; Arya A; Dagres N; Husser D; Bollmann A; Hindricks G; Müssigbrodt A
Sci Rep; 2021 Jun; 11(1):12411. PubMed ID: 34127728
[TBL] [Abstract][Full Text] [Related]
8. Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy.
Essayagh B; Resseguier N; Michel N; Casalta AC; Renard S; Donghi V; Carbone A; Piazzai C; Ambrosi P; Levy F; Martel H; Gérard H; Avierinos JF; N'Guyen K; Habib G
Arch Cardiovasc Dis; 2021 Feb; 114(2):96-104. PubMed ID: 33039326
[TBL] [Abstract][Full Text] [Related]
9. Relationships between P wave dispersion, atrial electromechanical delay, left atrial remodeling, and NT-proBNP levels, in patients with hypertrophic cardiomyopathy.
Tuluce K; Ozerkan F; Yakar Tuluce S; Yavuzgil O; Gurgun C; Bilgin M; Kahya Eren N; Kocabas U; Nalbantgil S; Soydas Cinar C
Cardiol J; 2015; 22(1):94-100. PubMed ID: 24671901
[TBL] [Abstract][Full Text] [Related]
10. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
11. Right Ventricular and Right Atrial Involvement Can Predict Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy?
Doesch C; Lossnitzer D; Rudic B; Tueluemen E; Budjan J; Haubenreisser H; Henzler T; Schoenberg SO; Borggrefe M; Papavassiliu T
Int J Med Sci; 2016; 13(1):1-7. PubMed ID: 26812947
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction.
Liu L; Wu L; Zheng L; Ding L; Chen G; Fan X; Yao Y
Int Heart J; 2019 Mar; 60(2):327-335. PubMed ID: 30626765
[TBL] [Abstract][Full Text] [Related]
13. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance.
Maron BJ; Haas TS; Maron MS; Lesser JR; Browning JA; Chan RH; Olivotto I; Garberich RF; Schwartz RS
Am J Cardiol; 2014 Apr; 113(8):1394-400. PubMed ID: 24589281
[TBL] [Abstract][Full Text] [Related]
14. Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.
Vasquez N; Ostrander BT; Lu DY; Ventoulis I; Haileselassie B; Goyal S; Greenland GV; Vakrou S; Olgin JE; Abraham TP; Abraham MR
J Am Soc Echocardiogr; 2019 May; 32(5):593-603.e1. PubMed ID: 30904367
[TBL] [Abstract][Full Text] [Related]
15. Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy.
Klopotowski M; Kwapiszewska A; Kukula K; Jamiolkowski J; Dabrowski M; Derejko P; Oreziak A; Baranowski R; Spiewak M; Marczak M; Klisiewicz A; Szepietowska B; Chmielak Z; Witkowski A
Clin Cardiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30120784
[TBL] [Abstract][Full Text] [Related]
16. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance.
Shigematsu Y; Hamada M; Nagai T; Nishimura K; Inoue K; Suzuki J; Ogimoto A; Higaki J
J Cardiol; 2011 Jul; 58(1):18-25. PubMed ID: 21515029
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
[TBL] [Abstract][Full Text] [Related]
18. E/e' ratio and left atrial area are predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Costabel JP; Galve E; Terricabras M; Ametrano C; Ronderos R; Baranchuk A; Evangelista A; Avegliano G
Echocardiography; 2018 Jul; 35(7):935-940. PubMed ID: 29505666
[TBL] [Abstract][Full Text] [Related]
19. Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy.
Farhad H; Seidelmann SB; Vigneault D; Abbasi SA; Yang E; Day SM; Colan SD; Russell MW; Towbin J; Sherrid MV; Canter CE; Shi L; Jerosch-Herold M; Bluemke DA; Ho C; Neilan TG
J Cardiovasc Magn Reson; 2017 Dec; 19(1):107. PubMed ID: 29284499
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
